Johnson & Johnson on Tuesday reported third-quarter earnings and revenue that beat expectations, boosted by higher sales of cancer and other prescription drugs, despite multimillion-dollar legal problems from talc and opioids. Here’s what the company reported compared with Wall Street estimates, based on a survey of analysts by Refinitiv: Adjusted earnings per share: $ 2.12… Read More »
September 26, 2019 Posted By Categories Gary Schwitzer is the founder and publisher of HealthNewsReview.org. He tweets as @garyschwitzer, or at @HealthNewsRevu. For the past 11 years, HealthNewsReview.org has helped journalists find industry-independent experts to use as sources in their stories. It’s an effort begun by journalists Jeanne Lenzer and Shannon Brownlee (now a VP… Read More »
House Speaker Nancy Pelosi’s bill to let the government negotiate prices on some drugs would save the government $ 345 billion over seven years but stifle innovation of new treatments and cures, according to a new analysis from the Congressional Budget Office. Democrats are likely to use the findings, from an initial report from the… Read More »
(This 13th October story has been refiled to add dropped word to paragraph 1) FILE PHOTO: White sugar products are placed for sale at a supermarket in Beijing, China September 4, 2017. REUTERS/Jason Lee/File Photo By Maytaal Angel and Hallie Gu LONDON/BEIJING (Reuters) – A crackdown on sugar smuggling into China has left abundantly supplied… Read More »